Torthaí cuardaigh - Marja‐Riitta Taskinen

Beachtaigh na torthaí
  1. 1
    Diabetic dyslipidaemia: from basic research to clinical practice*

    Diabetic dyslipidaemia: from basic research to clinical practice* de réir Marja‐Riitta Taskinen

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?

    Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease? de réir Marja‐Riitta Taskinen, Jan Borén

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes

    Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes de réir Marja‐Riitta Taskinen, Esko A. Nikkil�

    Foilsithe / Cruthaithe 1979
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.

    Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. de réir Mikko Syvänne, H. Hilden, Marja‐Riitta Taskinen

    Foilsithe / Cruthaithe 1994
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

    Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD de réir Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Dietary Fructose and the Metabolic Syndrome

    Dietary Fructose and the Metabolic Syndrome de réir Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Causes and Consequences of Hypertriglyceridemia

    Causes and Consequences of Hypertriglyceridemia de réir Chris J. Packard, Jan Borén, Marja‐Riitta Taskinen

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

    The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans de réir Jan Borén, Chris J. Packard, Marja‐Riitta Taskinen

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Lipoprotein lipase activity and serum lipoproteins in untreated Type 2 (insulin-independent) diabetes associated with obesity

    Lipoprotein lipase activity and serum lipoproteins in untreated Type 2 (insulin-independent) diabetes associated with obesity de réir Marja‐Riitta Taskinen, E. A. Nikkil�, T Kuusi, Kari Harno

    Foilsithe / Cruthaithe 1982
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Ectopic lipid storage and insulin resistance: a harmful relationship

    Ectopic lipid storage and insulin resistance: a harmful relationship de réir Jan Borén, Marja‐Riitta Taskinen, S.‐O. Olofsson, Malin Levin

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    The insulin resistance syndrome in smokers is related to smoking habits.

    The insulin resistance syndrome in smokers is related to smoking habits. de réir Björn Eliasson, Stig Attvall, Marja‐Riitta Taskinen, Ulf Smith

    Foilsithe / Cruthaithe 1994
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Effect of HDL composition and particle size on the resistance of HDL to the oxidation

    Effect of HDL composition and particle size on the resistance of HDL to the oxidation de réir Shuhei Nakanishi, Sanni Söderlund, Matti Jauhiainen, Marja‐Riitta Taskinen

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy.

    Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy. de réir John D. Bagdade, W E Buchanan, T Kuusi, Marja‐Riitta Taskinen

    Foilsithe / Cruthaithe 1990
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome

    Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome de réir Martin Adiels, Sven‐Olof Olofsson, Marja‐Riitta Taskinen, Jan Borén

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.

    Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy. de réir Marja‐Riitta Taskinen, Clifton Bogardus, Andrew Kennedy, Barbara V. Howard

    Foilsithe / Cruthaithe 1985
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes.

    Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. de réir Marja‐Riitta Taskinen, T Kuusi, Eero Helve, Esko A. Nikkilä, Hannele Yki‐Järvinen

    Foilsithe / Cruthaithe 1988
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Changes of lipolytic enzymes cluster with insulin resistance syndrome

    Changes of lipolytic enzymes cluster with insulin resistance syndrome de réir P. Knudsen, J. Eriksson, S. Lahdenper�, Juhani Kahri, L. Groop, Marja‐Riitta Taskinen

    Foilsithe / Cruthaithe 1995
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Modulation of hepatic glucose production by non-esterified fatty acids in Type 2 (non-insulin-dependent) diabetes mellitus

    Modulation of hepatic glucose production by non-esterified fatty acids in Type 2 (non-insulin-dependent) diabetes mellitus de réir Carola Saloranta, A. Franssila-Kallunki, Agneta Ekstrand, Marja‐Riitta Taskinen, Leif Groop

    Foilsithe / Cruthaithe 1991
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Circulating Oxidized Low-Density Lipoprotein and Its Association With Carotid Intima-Media Thickness in Asymptomatic Members of Familial Combined Hyperlipidemia Families

    Circulating Oxidized Low-Density Lipoprotein and Its Association With Carotid Intima-Media Thickness in Asymptomatic Members of Familial Combined Hyperlipidemia Families de réir Ming‐Lin Liu, Kati Ylitalo, Riitta Salonen, Jukka T. Salonen, Marja‐Riitta Taskinen

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes

    The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes de réir Bo Isomaa, Marianne Henricsson, P. Almgren, Jaakko Tuomilehto, Marja‐Riitta Taskinen, L. Groop

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: